ArticleMetabolic brain disease2025
A tetrahydropyrimidine derivative demonstrates neuroprotection against ketamine-induced schizophrenia through moderating oxidative and inflammatory markers.
Tayyaba Tahir et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it